无诱因静脉血栓栓塞症患者隐匿性癌症风险评分:个体患者数据Meta分析结果
本研究通过个体患者数据Meta分析评估RIETE评分与SOME评分对无诱因静脉血栓栓塞症患者隐匿性癌症的预测性能。RIETE评分在1753例患者中可计算,汇总ROC曲线下面积为0.59(95%CI 0.52-0.66;I²=0%);SOME评分在925例患者中可计算,汇总ROC曲线下面积为0.56(95%CI 0.46-0.65;I²=46%)。两种评分的预测区分性能均较差,结果不支持在日常临床实践中使用这些评分。
要点
- RIETE评分汇总ROC曲线下面积0.59(95%CI 0.52-0.66;I²=0%),区分性能差。
- SOME评分汇总ROC曲线下面积0.56(95%CI 0.46-0.65;I²=46%),区分性能差。
- RIETE高危组癌症5.9% vs 低危组2.9%(HR 2.0;95%CI 1.3-3.4)。
核心结论
- 两种评分的预测区分性能均较差。
- RIETE评分二分类使用时能区分低危与高危患者,但主要由高龄驱动。
- 结果不支持在日常临床实践中使用这些评分。
研究设计与样本
- 个体患者数据Meta分析,纳入连续成年的无诱因静脉血栓栓塞症患者,且接受方案规定的癌症筛查。
- 主要结局为随访30天至2年间的癌症诊断。
- 通过随机效应Meta分析计算受试者工作特征(ROC)曲线下面积评估区分性能。
主要发现
- RIETE评分可计算于1753例患者,其中63例(3.6%)诊断为癌症,汇总ROC曲线下面积0.59(95%CI 0.52-0.66;I²=0%)。
- RIETE评分高危组427例(24%)中25例(5.9%)诊断为癌症,低危组1326例中38例(2.9%)诊断为癌症(HR 2.0;95%CI 1.3-3.4)。
- SOME评分可计算于925例患者,其中37例(4.0%)诊断为癌症,汇总ROC曲线下面积0.56(95%CI 0.46-0.65;I²=46%)。
- SOME评分高危组(≥2分)161例(17%)中8例(5.0%)诊断为癌症,低危组764例中29例(3.8%)诊断为癌症(HR 1.2;95%CI 0.55-2.7)。
关键数值与推荐
- RIETE评分高危组癌症5.9% vs 低危组2.9%(HR 2.0;95%CI 1.3-3.4)。
- SOME评分高危组(≥2分)癌症5.0% vs 低危组3.8%(HR 1.2;95%CI 0.55-2.7)。
- RIETE评分汇总ROC曲线下面积0.59(95%CI 0.52-0.66;I²=0%)。
- SOME评分汇总ROC曲线下面积0.56(95%CI 0.46-0.65;I²=46%)。
临床怎么用
- 原文结论指出结果不支持在日常临床实践中使用这些评分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Registro Informatizado de Pacientes con Enfermedad TromboEmbólica (RIETE) score and the Screening for Occult Malignancy in Patients with Idiopathic Venous Thromboembolism (SOME) risk scores aim to identify patients with acute unprovoked venous thromboembolism (VTE) at high risk of occult cancer, but their predictive performance is unclear. METHODS: The scores were evaluated in an individual patient data meta-analysis. Studies were eligible if enrolling consecutive adults with unprovoked VTE who underwent protocol-mandated screening for cancer. The primary outcome was a cancer diagnosis between 30 days and 2 years of follow-up. The discriminatory performance was evaluated by computing the area under the receiver (ROC) curve in random-effects meta-analyses. RESULTS: The RIETE score could be calculated in 1753 patients, of whom 63 (3.6%) were diagnosed with cancer. The pooled area under the ROC curve was 0.59 (95% confidence interval [CI], 0.52-0.66; I2 = 0%). Of the 427 patients (24%) classified as high risk, 25 (5.9%) were diagnosed with cancer compared with 38 of 1326 (2.9%) low-risk patients (hazard ratio [HR], 2.0; 95% CI, 1.3-3.4). The SOME score was calculated in 925 patients, of whom 37 (4.0%) were diagnosed with cancer. The pooled area under the ROC curve was 0.56 (95% CI, 0.46-0.65; I2 = 46%). Of the 161 patients (17%) classified as high risk (≥2 points), eight (5.0%) were diagnosed with cancer compared with 29 of 764 (3.8%) low-risk patients (HR, 1.2; 95% CI, 0.55-2.7). CONCLUSIONS: The predictive discriminatory performance of both scores is poor. When used dichotomously, the RIETE score is able to discriminate between low- and high-risk patients. Because this is largely driven by advanced age, these results do not support the use of these scores in daily clinical practice.
引用
- Mulder FI, Carrier M, van Doormaal F, et al. Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis. J Thromb Haemost. 2020. PMID: 32654348. doi:10.1111/jth.15001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。